Cardiometabolic Health Congress

JULY 25, 2024

Here’s what you can expect at the biggest conference in cardiorenal metabolic health, the 19th Annual Cardiometabolic Congress (CMHC), DECODING THE CONSTELLATION of Cardiometabolic Health and Risk Factors. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education 100

Education Innovation Risk Factors Obesity 100

Cardiometabolic Health Congress

JULY 12, 2023

A vast collection of webinars, CME activities, expert interviews, on-demand event recordings, news articles, drug pipelines, and many other resources are now grouped into areas of specialty focus. ” Learners can see some of the CMHC experts in person on Aug.

Education 40

Education Webinar CME Pediatrics 40

Cardiometabolic Health Congress

FEBRUARY 23, 2024

When we explore the three traditional cardiometabolic risk factors (obesity, type 2 diabetes, and dyslipidemia) and the emerging cardiometabolic risk factor of non-alcoholic fatty liver disease, we unearth a complex interplay of societal, biological, genetic, and environmental factors. . #1

Risk Factors 105

Risk Factors Health Disparities Education CME 105

Cardiometabolic Health Congress

NOVEMBER 14, 2024

cardiometabolic health CME/CE conference: the 19th Annual CMHC. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors.

CME 103

CME Obesity Heart Failure Biomarkers 103

Cardiometabolic Health Congress

NOVEMBER 8, 2024

Leverage Medications with Dual Benefits : GLP-1 agonists, statins, and pioglitazone offer broad benefits for managing both MASH and cardiometabolic risk factors. Monitor Cardiovascular Risk : Statin therapy and managing conditions like hypertension and T2D are crucial for reducing the risk of cardiovascular events in MASH patients.

Obesity 52

Obesity Exercise Risk Factors Cardiovascular Disease 52